<li>amitriptyline<p>simvastatin will increase the level or effect of amitriptyline by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>atorvastatin<p>simvastatin will increase the level or effect of atorvastatin by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>azithromycin<p>simvastatin will increase the level or effect of azithromycin by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>bazedoxifene/conjugated estrogens<p>simvastatin will increase the level or effect of bazedoxifene/conjugated estrogens by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>budesonide<p>simvastatin will increase the level or effect of budesonide by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>carbamazepine<p>carbamazepine will increase the level or effect of simvastatin by  Other (see comment). Use Caution/Monitor. OATP1B1 inhibitors may increase risk of myopathy</p></li><li>caspofungin<p>caspofungin will increase the level or effect of simvastatin by  Other (see comment). Use Caution/Monitor. OATP1B1 inhibitors may increase risk of myopathy</p></li><li>ceritinib<p>simvastatin increases levels of ceritinib by P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>cholestyramine<p>cholestyramine decreases levels of ezetimibe by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor. Separate by 2-4 hours.<span><br><br></span>cholestyramine decreases levels of simvastatin by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.</p></li><li>cholic acid<p>simvastatin increases toxicity of cholic acid by decreasing elimination. Modify Therapy/Monitor Closely. Avoid concomitant use of inhibitors of the bile salt efflux pump (BSEP). May exacerbate accumulation of conjugated bile salts in the liver and result in clinical symptoms. If concomitant use is necessary, monitor serum transaminases and bilirubin.</p></li><li>sofosbuvir/velpatasvir<p>sofosbuvir/velpatasvir increases levels of ezetimibe by Other (see comment). Use Caution/Monitor. 
Comment: Velpatasvir inhibits OATP1B1, OATP1B3, and OATP2B1 transporters. .</p></li>